
    
      After consent and screening, patients will be initiated on 5mg or 10mg per day of olanzapine.
      Olanzapine doses will be titrated to 10-20 mg of olanzapine over one week, to a maximum of
      20mg by day 21. Patients will also receive either topiramate (25mg bid titrated over 18 days
      to 150 mg bid. with flexibility to titrate to 200mg bid) or matched placebo. Topiramate will
      be initiated at a dose of 25 mg bid and will be increased by 25 mg bid every three days as
      tolerated. Patients will be evaluated by a blinded (to treatment status and adverse events)
      rater.
    
  